Combined Dipeptidyl Peptidase 4 Inhibitor and α-Glucosidase Inhibitor Treatment in Postprandial Hypoglycemia.
作者信息
Broome David T, Kodali Alimitha, Phillips Danielle, Makin Vinni, Mendlovic Daniel, Zimmerman Robert S
机构信息
Department of Endocrinology, Diabetes & Metabolism, Cleveland Clinic Foundation, Cleveland, OH.
Cleveland Clinic Anesthesiology Institute, Cleveland Clinic Foundation, Cleveland, OH.
出版信息
Clin Diabetes. 2022 Jan;40(1):116-119. doi: 10.2337/cd21-0042.
Abstract
摘要
相似文献
1
Combined Dipeptidyl Peptidase 4 Inhibitor and α-Glucosidase Inhibitor Treatment in Postprandial Hypoglycemia.二肽基肽酶4抑制剂与α-葡萄糖苷酶抑制剂联合治疗餐后低血糖症
Clin Diabetes. 2022 Jan;40(1):116-119. doi: 10.2337/cd21-0042.
2
Comparison of efficacies of a dipeptidyl peptidase IV inhibitor and alpha-glucosidase inhibitors in oral carbohydrate and meal tolerance tests and the effects of their combination in mice.二肽基肽酶IV抑制剂与α-葡萄糖苷酶抑制剂在小鼠口服碳水化合物和餐耐量试验中的疗效比较及其联合应用的效果
J Pharmacol Sci. 2007 May;104(1):29-38. doi: 10.1254/jphs.fp0061376. Epub 2007 May 8.
3
Cerebrovascular Complications of Diabetes: Alpha Glucosidase Inhibitor as Potential Therapy.糖尿病的脑血管并发症：α-葡萄糖苷酶抑制剂作为潜在治疗方法
Horm Metab Res. 2016 Feb;48(2):83-91. doi: 10.1055/s-0035-1565181. Epub 2015 Nov 17.
4
Synergistic effect of α-glucosidase inhibitors and dipeptidyl peptidase 4 inhibitor treatment.α-葡萄糖苷酶抑制剂与二肽基肽酶-4 抑制剂联合治疗的协同作用。
J Diabetes Investig. 2011 Jun 5;2(3):200-3. doi: 10.1111/j.2040-1124.2010.00081.x.
5
Steroidal saponins from Trillium govanianum as α-amylase, α-glucosidase, and dipeptidyl peptidase IV inhibitory agents.玉竹甾体皂苷作为α-淀粉酶、α-葡萄糖苷酶和二肽基肽酶 IV 抑制剂。
J Pharm Pharmacol. 2021 Mar 8;73(4):487-495. doi: 10.1093/jpp/rgaa038.
6
[Hypoglycemia in the diabetes treatment - risk minimization with dipeptidyl peptidase-4 inhibitors].[糖尿病治疗中的低血糖——使用二肽基肽酶-4抑制剂将风险降至最低]
Drugs Today (Barc). 2010 Dec;46 Suppl F:1-12.
7
Inhibitory effect of chestnut (Castanea mollissima Blume) inner skin extract on the activity of α-amylase, α-glucosidase, dipeptidyl peptidase IV and in vitro digestibility of starches.板栗（Castanea mollissima Blume）内种皮提取物对α-淀粉酶、α-葡萄糖苷酶、二肽基肽酶 IV 活性及淀粉体外消化率的抑制作用。
Food Chem. 2020 Sep 15;324:126847. doi: 10.1016/j.foodchem.2020.126847. Epub 2020 Apr 18.
8
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with alpha-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin-1): A multicenter, randomized, open-label, non-inferiority trial.西他列汀对比α-葡萄糖苷酶抑制剂在二甲双胍或吡格列酮单药治疗控制不佳的日本 2 型糖尿病患者中的疗效和安全性（使用西他列汀进行终极联合治疗控制糖尿病研究 1）：一项多中心、随机、开放标签、非劣效性试验。
J Diabetes Investig. 2015 Mar;6(2):182-91. doi: 10.1111/jdi.12282. Epub 2014 Sep 24.
9
The Inhibitory Effects of New Zealand Pine Bark (Enzogenol) on α-Amylase, α-Glucosidase, and Dipeptidyl Peptidase-4 (DPP-4) Enzymes.新西兰松皮（恩杂鲁胺）对α-淀粉酶、α-葡萄糖苷酶和二肽基肽酶-4（DPP-4）的抑制作用。
Nutrients. 2022 Apr 12;14(8):1596. doi: 10.3390/nu14081596.
10
Anti-α-glucosidase and Anti-dipeptidyl Peptidase-IV Activities of Extracts and Purified Compounds from Vitis thunbergii var. taiwaniana.台湾山葡萄提取物及纯化化合物的抗α-葡萄糖苷酶和抗二肽基肽酶-IV活性
J Agric Food Chem. 2015 Jul 22;63(28):6393-401. doi: 10.1021/acs.jafc.5b02069. Epub 2015 Jul 13.
本文引用的文献
1
Postprandial Reactive Hypoglycemia.餐后反应性低血糖
Sisli Etfal Hastan Tip Bul. 2019 Aug 28;53(3):215-220. doi: 10.14744/SEMB.2019.59455. eCollection 2019.
2
Global status of diabetes prevention and prospects for action: A consensus statement.全球糖尿病预防现状及行动展望：共识声明。
Diabetes Metab Res Rev. 2018 Sep;34(6):e3021. doi: 10.1002/dmrr.3021. Epub 2018 Jun 8.
3
[Sitaglitpin phosphate treatment in patients with reactive hypoglycemia secondary to dysinsulinism. Controlled, randomized, double-blind study].[磷酸西他列汀治疗胰岛素分泌异常继发反应性低血糖患者。对照、随机、双盲研究]
Gac Med Mex. 2017;153(Supl. 2):S51-S59. doi: 10.24875/GMM.M17000007.
4
Efficacy and safety of combination therapy with an α-glucosidase inhibitor and a dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: A systematic review with meta-analysis.α-葡萄糖苷酶抑制剂与二肽基肽酶-4 抑制剂联合治疗 2 型糖尿病患者的疗效和安全性：系统评价和荟萃分析。
J Diabetes Investig. 2018 Jul;9(4):893-902. doi: 10.1111/jdi.12754. Epub 2017 Oct 25.
5
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.二肽基肽酶（DPP）-4抑制剂和胰高血糖素样肽（GLP）-1类似物用于预防或延缓2型糖尿病高危人群发生2型糖尿病及其相关并发症。
Cochrane Database Syst Rev. 2017 May 10;5(5):CD012204. doi: 10.1002/14651858.CD012204.pub2.
6
Single-dose acarbose decreased glucose-dependent insulinotropic peptide and glucagon levels in Chinese patients with newly diagnosed type 2 diabetes mellitus after a mixed meal.单剂量阿卡波糖可降低中国新诊断2型糖尿病患者混合餐后的葡萄糖依赖性促胰岛素多肽和胰高血糖素水平。
BMC Endocr Disord. 2016 Sep 29;16(1):55. doi: 10.1186/s12902-016-0133-7.
7
Sitagliptin improves glycaemic excursion after a meal or after an oral glucose load in Japanese subjects with impaired glucose tolerance.在糖耐量受损的日本受试者中，西他列汀可改善餐后或口服葡萄糖负荷后的血糖波动。
Diabetes Obes Metab. 2015 Nov;17(11):1033-41. doi: 10.1111/dom.12507. Epub 2015 Jul 17.
8
Idiopathic accelerated gastric emptying presenting in adults with post-prandial diarrhea and reactive hypoglycemia: a case series.成人出现餐后腹泻和反应性低血糖的特发性胃排空加速：病例系列
J Med Case Rep. 2012 May 19;6:132. doi: 10.1186/1752-1947-6-132.
9
Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance.二肽基肽酶-IV抑制剂维格列汀对糖耐量受损受试者肠促胰岛素激素、胰岛功能及餐后血糖的影响。
Diabetes Care. 2008 Jan;31(1):30-5. doi: 10.2337/dc07-1616. Epub 2007 Oct 18.
10
Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes.二肽基肽酶-4抑制对2型糖尿病患者胃肠功能、进餐情况及糖代谢的影响
Diabetes. 2007 May;56(5):1475-80. doi: 10.2337/db07-0136. Epub 2007 Feb 15.
Zotero 插件